透明质酸钠联合Ahmed青光眼阀治疗难治性青光眼  

Sodium hyaluronate combined with Ahmed glaucoma valve for refractory glaucoma

作　　者：王晋瑛[1] 高媛[1] 

机构地区：[1]中国湖北省武汉市第一医院眼科,430022

出　　处：《国际眼科杂志》2011年第1期133-134,共2页International Eye Science

摘　　要：目的:探讨透明质酸钠联合青光眼阀治疗难治性青光眼的中远期疗效,探讨手术并发症的预防和处理。方法:采用透明质酸钠联合青光眼阀治疗难治性青光眼27例27眼,术后随访6～22mo。结果:术前眼压46.70±9.31mmHg,术后降至20.60±7.31mmHg,视力有不同程度的提高。术后并发症1例阀门管位置欠佳,经调整后得到改善,2例前房积血,用药后吸收。结论:使用透明质酸钠联合Ahmed青光眼阀植入,可以有效地降低难治性青光眼的眼压,减少术后并发症的发生。AIM： To investigate the the long-term efficacy of combination of sodium hyaluronate and Ahmed glaucoma valve for refractory glaucoma and the prevention and treatment for surgical complications. METHODS： Twenty-seven patients 27 eyes with refractory glaucoma were treated with sodium hyaluronate and Ahmed glaucoma valve and followed up from 6 to 22 months. RESULTS： Postoperative intraocular pressure （IOP） declined from 46.70±9.31mmHg preoperatively to 187±6.85mmHg. Visual acuity was improved to some extent. Displacement of glaucoma valve was found in 1 case and improved with adjustment. Hyphema was found in 2 cases and absorbed with medication. CONCLUSION： Sodium hyaluronate combined with Ahmed glaucoma valve can effectively reduce the IOP in patients with refractory glaucoma and decrease the postoperative complications.

关 键 词：难治性青光眼 透明质酸钠 AHMED青光眼阀 

分 类 号：R779.6[医药卫生—眼科]